| 1 |
Brown AM, Butman JL, Lengacher R, Vargo NP, Martin KE, Koller A, Śmiłowicz D, Boros E, Robinson JR. N,N-Alkylation Clarifies the Role of N- and O-Protonated Intermediates in Cyclen-Based (64)Cu Radiopharmaceuticals. Inorg Chem 2023;62:1362-76. [PMID: 36490364 DOI: 10.1021/acs.inorgchem.2c02907] [Reference Citation Analysis]
|
| 2 |
Sun J, Huangfu Z, Yang J, Wang G, Hu K, Gao M, Zhong Z. Imaging-guided targeted radionuclide tumor therapy: From concept to clinical translation. Adv Drug Deliv Rev 2022;190:114538. [PMID: 36162696 DOI: 10.1016/j.addr.2022.114538] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Calatayud DG, Neophytou S, Nicodemou E, Giuffrida SG, Ge H, Pascu SI. Nano-Theranostics for the Sensing, Imaging and Therapy of Prostate Cancers. Front Chem 2022;10:830133. [DOI: 10.3389/fchem.2022.830133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 4 |
Neels O, Kratochwil C, Patt M. Aktuelle radiopharmazeutische Entwicklungen für die theranostische Anwendung. Radiopraxis 2021;14:E83-E98. [DOI: 10.1055/a-1525-6335] [Reference Citation Analysis]
|
| 5 |
Tapia L, Alfonso I, Solà J. Molecular cages for biological applications. Org Biomol Chem 2021;19:9527-40. [PMID: 34668919 DOI: 10.1039/d1ob01737c] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 6 |
Choiński J, Łyczko M. Prospects for the production of radioisotopes and radiobioconjugates for theranostics. Bio-Algorithms and Med-Systems 2022;17:241-57. [DOI: 10.1515/bams-2021-0136] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 7 |
Filippi L, Frantellizzi V, Sidrak MMA, Gorica J, Scippa S, Chiaravalloti A, Schillaci O, Bagni O, De Vincentis G. Radiotheranostic Agents Targeting Neuroblastoma: State-of-the-Art and Emerging Perspectives. Onco 2021;1:123-139. [DOI: 10.3390/onco1020011] [Reference Citation Analysis]
|
| 8 |
Neels O, Kratochwil C, Patt M. Aktuelle radiopharmazeutische Entwicklungen für die theranostische Anwendung. Der Nuklearmediziner 2021;44:135-151. [DOI: 10.1055/a-1474-8976] [Reference Citation Analysis]
|
| 9 |
Rudd SE, Van Zuylekom JK, Raicevic A, Pearce LA, Cullinane C, Williams CC, Adams TE, Hicks RJ, Donnelly PS. Enzyme mediated incorporation of zirconium-89 or copper-64 into a fragment antibody for same day imaging of epidermal growth factor receptor. Chem Sci 2021;12:9004-16. [PMID: 34276928 DOI: 10.1039/d1sc01422f] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 10 |
Carbo‐bague I, Ramogida CF. Emerging Therapeutic Radiopharmaceuticals and Their Theranostic Pairs. Encyclopedia of Inorganic and Bioinorganic Chemistry 2021. [DOI: 10.1002/9781119951438.eibc2763] [Reference Citation Analysis]
|
| 11 |
Farleigh M, Pham TT, Yu Z, Kim J, Sunassee K, Firth G, Forte N, Chudasama V, Baker JR, Long NJ, Rivas C, Ma MT. New Bifunctional Chelators Incorporating Dibromomaleimide Groups for Radiolabeling of Antibodies with Positron Emission Tomography Imaging Radioisotopes. Bioconjug Chem 2021;32:1214-22. [PMID: 33724798 DOI: 10.1021/acs.bioconjchem.0c00710] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Dearling JLJ, van Dam EM, Harris MJ, Packard AB. Detection and therapy of neuroblastoma minimal residual disease using [64/67Cu]Cu-SARTATE in a preclinical model of hepatic metastases. EJNMMI Res 2021;11:20. [PMID: 33630166 DOI: 10.1186/s13550-021-00763-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 13 |
Morgan KA, Donnelly PS. Metallic radionuclides for diagnostic imaging and cancer radiotherapy: The development of theragnostic matched pairs and targeted alpha therapy. Recent Highlights I 2021. [DOI: 10.1016/bs.adioch.2021.05.002] [Reference Citation Analysis]
|
| 14 |
Keinänen O, Fung K, Brennan JM, Zia N, Harris M, van Dam E, Biggin C, Hedt A, Stoner J, Donnelly PS, Lewis JS, Zeglis BM. Harnessing 64Cu/67Cu for a theranostic approach to pretargeted radioimmunotherapy. Proc Natl Acad Sci U S A 2020;117:28316-27. [PMID: 33106429 DOI: 10.1073/pnas.2009960117] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 15 |
Eychenne R, Bouvry C, Bourgeois M, Loyer P, Benoist E, Lepareur N. Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy. Molecules 2020;25:E4012. [PMID: 32887456 DOI: 10.3390/molecules25174012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 16 |
Houston ZH, Bunt J, Chen KS, Puttick S, Howard CB, Fletcher NL, Fuchs AV, Cui J, Ju Y, Cowin G, Song X, Boyd AW, Mahler SM, Richards LJ, Caruso F, Thurecht KJ. Understanding the Uptake of Nanomedicines at Different Stages of Brain Cancer Using a Modular Nanocarrier Platform and Precision Bispecific Antibodies. ACS Cent Sci 2020;6:727-38. [PMID: 32490189 DOI: 10.1021/acscentsci.9b01299] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 17 |
Krasikova RN. Potential of PET in Tumor Theranostics. Radiochemistry 2019;61:645-55. [DOI: 10.1134/s1066362219060018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 18 |
Zia NA, Cullinane C, Van Zuylekom JK, Waldeck K, Mcinnes LE, Buncic G, Haskali MB, Roselt PD, Hicks RJ, Donnelly PS. A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper‐64 with High Tumor Uptake and Retention. Angew Chem 2019;131:15133-15136. [DOI: 10.1002/ange.201908964] [Reference Citation Analysis]
|
| 19 |
Voss SD. Functional and anatomical imaging in pediatric oncology: which is best for which tumors. Pediatr Radiol 2019;49:1534-44. [PMID: 31620853 DOI: 10.1007/s00247-019-04489-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 20 |
Ling X, Cutler CS, Anderson CJ. The Radiopharmaceutical Chemistry of the Radioisotopes of Copper. Radiopharmaceutical Chemistry 2019. [DOI: 10.1007/978-3-319-98947-1_19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 21 |
States LJ, Voss SD. PET/CT in Pediatric Oncology. Pediatric Oncology 2019. [DOI: 10.1007/978-3-030-03777-2_3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 22 |
Hicks RJ, Jackson P, Kong G, Ware RE, Hofman MS, Pattison DA, Akhurst TA, Drummond E, Roselt P, Callahan J, Price R, Jeffery CM, Hong E, Noonan W, Herschtal A, Hicks LJ, Hedt A, Harris M, Paterson BM, Donnelly PS. 64Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy. J Nucl Med 2019;60:777-85. [PMID: 30442752 DOI: 10.2967/jnumed.118.217745] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 11.8] [Reference Citation Analysis]
|
| 23 |
Rylova SN, Stoykow C, Del Pozzo L, Abiraj K, Tamma ML, Kiefer Y, Fani M, Maecke HR. The somatostatin receptor 2 antagonist 64Cu-NODAGA-JR11 outperforms 64Cu-DOTA-TATE in a mouse xenograft model. PLoS One 2018;13:e0195802. [PMID: 29668724 DOI: 10.1371/journal.pone.0195802] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 24 |
Jamier V, Mume E, Papamicaël C, Smith SV. Exploring the synthesis and metal complexation behavior of mono and bis substituted hexaazamacrocyclic cage derivatives. Inorganic Chemistry Communications 2017;82:48-51. [DOI: 10.1016/j.inoche.2017.03.039] [Reference Citation Analysis]
|
| 25 |
Yap ML, McFadyen JD, Wang X, Zia NA, Hohmann JD, Ziegler M, Yao Y, Pham A, Harris M, Donnelly PS, Hogarth PM, Pietersz GA, Lim B, Peter K. Targeting Activated Platelets: A Unique and Potentially Universal Approach for Cancer Imaging. Theranostics 2017;7:2565-74. [PMID: 28819447 DOI: 10.7150/thno.19900] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 26 |
Marciniak A, Brasuń J. Somatostatin analogues labeled with copper radioisotopes: current status. J Radioanal Nucl Chem 2017;313:279-89. [PMID: 28804185 DOI: 10.1007/s10967-017-5323-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 27 |
Voloshin Y, Belaya I, Krämer R. Practical Applications of Cage Metal Complexes. Cage Metal Complexes 2017. [DOI: 10.1007/978-3-319-56420-3_5] [Reference Citation Analysis]
|
| 28 |
Imberti C, Terry SY, Cullinane C, Clarke F, Cornish GH, Ramakrishnan NK, Roselt P, Cope AP, Hicks RJ, Blower PJ, Ma MT. Enhancing PET Signal at Target Tissue in Vivo: Dendritic and Multimeric Tris(hydroxypyridinone) Conjugates for Molecular Imaging of αvβ3 Integrin Expression with Gallium-68. Bioconjug Chem 2017;28:481-95. [PMID: 27966893 DOI: 10.1021/acs.bioconjchem.6b00621] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 29 |
Ziegler M, Alt K, Paterson BM, Kanellakis P, Bobik A, Donnelly PS, Hagemeyer CE, Peter K. Highly Sensitive Detection of Minimal Cardiac Ischemia using Positron Emission Tomography Imaging of Activated Platelets. Sci Rep 2016;6:38161. [PMID: 27909290 DOI: 10.1038/srep38161] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 30 |
Zelinskii GE, Chuprin AS, Belov AS, Novikov VV, Vologzhanina AV, Lebed EG, Voloshin YZ. Template synthesis and X-ray structure of the tris-glyoximate iron(II) clathrochelates with terminal reactive groups. Inorganica Chimica Acta 2016;453:210-21. [DOI: 10.1016/j.ica.2016.08.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 31 |
Hicks RJ. Back to the Future: Nuclear Medicine Rediscovers Its Therapeutic Roots. Perspectives on Nuclear Medicine for Molecular Diagnosis and Integrated Therapy 2016. [DOI: 10.1007/978-4-431-55894-1_21] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 32 |
Paterson BM, Donnelly PS. Macrocyclic Bifunctional Chelators and Conjugation Strategies for Copper-64 Radiopharmaceuticals. Insights from Imaging in Bioinorganic Chemistry. Elsevier; 2016. pp. 223-51. [DOI: 10.1016/bs.adioch.2015.09.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 33 |
Ma MT, Cullinane C, Waldeck K, Roselt P, Hicks RJ, Blower PJ. Rapid kit-based (68)Ga-labelling and PET imaging with THP-Tyr(3)-octreotate: a preliminary comparison with DOTA-Tyr(3)-octreotate. EJNMMI Res 2015;5:52. [PMID: 26452495 DOI: 10.1186/s13550-015-0131-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 34 |
Ma MT, Cullinane C, Imberti C, Baguña Torres J, Terry SY, Roselt P, Hicks RJ, Blower PJ. New Tris(hydroxypyridinone) Bifunctional Chelators Containing Isothiocyanate Groups Provide a Versatile Platform for Rapid One-Step Labeling and PET Imaging with (68)Ga(3.). Bioconjug Chem 2016;27:309-18. [PMID: 26286399 DOI: 10.1021/acs.bioconjchem.5b00335] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 35 |
Ullman C, Mathonet P, Oleksy A, Diamandakis A, Tomei L, Demartis A, Nardi C, Sambucini S, Missineo A, Alt K, Hagemeyer CE, Harris M, Hedt A, Weis R, Gehlsen KR. High Affinity Binders to EphA2 Isolated from Abdurin Scaffold Libraries; Characterization, Binding and Tumor Targeting. PLoS One 2015;10:e0135278. [PMID: 26313909 DOI: 10.1371/journal.pone.0135278] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 36 |
Algarra AG. Computational Insights into the Isomerism of Hexacoordinate Metal–Sarcophagine Complexes: The Relationship between Structure and Stability. Eur J Inorg Chem 2015;2015:503-11. [DOI: 10.1002/ejic.201402984] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 37 |
Upadhyay RK. Drug delivery systems, CNS protection, and the blood brain barrier. Biomed Res Int 2014;2014:869269. [PMID: 25136634 DOI: 10.1155/2014/869269] [Cited by in Crossref: 182] [Cited by in F6Publishing: 210] [Article Influence: 20.2] [Reference Citation Analysis]
|
| 38 |
Cai Z, Ouyang Q, Zeng D, Nguyen KN, Modi J, Wang L, White AG, Rogers BE, Xie XQ, Anderson CJ. 64Cu-labeled somatostatin analogues conjugated with cross-bridged phosphonate-based chelators via strain-promoted click chemistry for PET imaging: in silico through in vivo studies. J Med Chem 2014;57:6019-29. [PMID: 24983404 DOI: 10.1021/jm500416f] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 39 |
Liu S, Li Z, Conti PS. Development of multi-functional chelators based on sarcophagine cages. Molecules 2014;19:4246-55. [PMID: 24705567 DOI: 10.3390/molecules19044246] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 40 |
Ling I, Sobolev AN, Hashim R, Harrowfield JM. Stereochemistry of cage amine complexes – probing the ligand conformational flexibility with hydrogen bonds. CrystEngComm 2014;16:11058-63. [DOI: 10.1039/c4ce01980f] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
